Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials

An increasing number of clinical trials are enrolling patients with myasthenia gravis (MG). A lack of standardization in the performance of outcome measures leads to confusion among site research teams and is a source of variability in clinical trial data. MGNet, the NIH-supported Rare Disease Clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Guptill, Jeffrey T., Benatar, Michael, Granit, Volkan, Habib, Ali A., Howard, James F., Barnett-Tapia, Carolina, Nowak, Richard J., Lee, Ikjae, Ruzhansky, Katherine, Dimachkie, Mazen M., Cutter, Gary R., Kaminski, Henry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Contemporary Issues in Practice, Education, & Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491448/
https://www.ncbi.nlm.nih.gov/pubmed/37076302
http://dx.doi.org/10.1212/WNL.0000000000207278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491448/
https://www.ncbi.nlm.nih.gov/pubmed/37076302
http://dx.doi.org/10.1212/WNL.0000000000207278

Ejemplares similares